Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026
Emily Bury, Advanced Nurse Practitioner for Thrombosis at St.Vincent’s Healthcare Group, shared a post on LinkedIn:
“A fantastic few days at ISTH 2026 in Paris, with rich learning, inspiring discussions and valuable opportunities to connect with colleagues from around the world.
It was exciting to see women’s health take centre stage, including the launch of the ‘Women’s Health Hub‘—a significant step towards advancing research, education and equitable care for women with thrombosis and bleeding disorders.
Another key highlight was the continued focus on ‘cancer-associated VTE‘, with the ‘API-CAT trial‘ demonstrating that extended treatment with ‘reduced-dose apixaban’ was non-inferior to the full treatment dose for preventing recurrent VTE, while reducing clinically relevant bleeding.
Delighted to attend alongside Tracy Egan of the Irish Heart Foundation – (supporting Thrombosis patients).
Looking forward to bringing insights from ISTH back to support better patient care.”
Stay updated with Hemostasis Today.
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?
-
Jul 20, 2026, 19:56Asima Ahmad: Decoding Heavy Bleeding – What Your Symptoms Could Be Telling You
-
Jul 20, 2026, 19:41Athma Dias: The Diagnostic Challenge of Inherited Platelet Function Disorders
-
Jul 20, 2026, 19:21Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
-
Jul 20, 2026, 19:06Sam Hirniak: Symptoms, Diagnosis, and Treatment for Women and Girls with Hemophilia
-
Jul 20, 2026, 18:29Masoabi Sefojane: Every Leadership Journey has it’s Season